Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Evidence-Based Management of Heart Failure & High Cholesterol


 
 
 
 
Program Overview
 
The prevalence of heart failure (HF) has increased from 5.7 million to 6.5 million Americans, contributing to one in eight deaths and accounting for almost 400,000 deaths each year.  High cholesterol currently affects 99 million Americans or 45% of the adult population.1,2  Not only is it important for clinicians to understand how these diseases will impact their patients, but they must also be able to navigate the ever-evolving landscape of evidence-based therapeutics that are available for treatment.  Recent advances in treatment developments plus guideline updates for both HF and high cholesterol has given clinicians more information and data than ever before to consider when caring for their patients. This activity will help pharmacists, physicians, physician assistants, nurse practitioners, and nurses to more effectively navigate evidence-based treatment options when caring for patients with heart failure and high cholesterol. 
 
1. Virani SS, Alonso A, Benjamin EJ, et al.  Heart Disease and Stroke Statistics – 2020 Update. Circulation. 2020;141(9):e139-596.
2. National Center for Chronic Disease Prevention, Division of Population Health. “Cholesterol.”  14 Aug. 2019.
 
 
 
Program Goal
 
The overall goal is to enhance participants' knowledge about heart failure, high cholesterol, and the variety of therapeutics that are available to treat these conditions.  In addition, participants will also learn how to navigate evolving evidence, research, and guidelines that must be considered when using these therapeutics in clinical practice.
 
 
 
Program Format
 
There are a total of 4 modules in this activity.  Each modules may be taken individually, in any order, or collectively for a more comprehensive look at the treatment of heart failure (HF) and high cholesterol.  Modules I and II will prime learners with baseline knowledge about HF and high cholesterol and their currently available treatments. Module III will review treatment guidelines, evidence-based data, and patient characteristics that must be considered when developing patient-centered treatment plans for HF and high cholesterol.  Module IV will discuss comorbid conditions and emerging therapeutics and their potential impact on the treatment of HF and high cholesterol.  Finally, all 4 modules will also include faculty-guided case exercises that give the learner practice applying the information.   
 
Each module consists of the following:  ** 
  • Presentation Video (didactic slide presentation) 
  • Case Exercise & Video (complete case exercise while viewing faculty-guided case discussion video)
  • Post-Test (score > 70% within 5 attempts)
  • Evaluation (CE credit is awarded at the end of each module, upon completion of the module evaluation)
**  The activity contents listed above are accessible once you register for the activity (green button at bottom).  
 
 
 
Target Audience
 
This activity is designed for pharmacists, nurses, nurse practitioners, physician assistants, and physicians who care for patients with heart failure and/or high cholesterol in a community practice setting.
 
 
 
Program Instructors / Planners
 
James A. Karboski, PharmD   [Planner + Instructor]
Clinical Professor of Pharmacy Practice 
The University of Texas at Austin College of Pharmacy
 
Kristin M. Janzen, PharmD, BCPS   [Instructor]
Clinical Assistant Professor
The University of Texas at Austin College of Pharmacy
 
Rebekka Adamson, PharmD, BCCP  [Instructor]
Clinical Pharmacy Specialist, Cardiology/Internal Medicine
Dell Seton Medical Center
 
Jennifer Bosworth, PharmD   [Planner]
Assistant Director, Continuing Pharmacy Education
The University of Texas at Austin College of Pharmacy
 
 
 
Financial Disclosures
 
Dr. Karboski has no financial relationships to disclose.
Dr. Janzen has no financial relationships to disclose.
Dr. Adamson has no financial relationships to disclose.
Dr. Bosworth has no financial relationships to disclose.
 
The University of Texas at Austin Continuing Pharmacy Education (UT CPE) requires instructors, planners, and other individuals who are in a position to control accredited content to disclose all financial relationships with ineligible companies (e.g. companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients) prior to the commencement of their role.  Regarding this activity, there are no relevant financial relationships that required mitigation prior to the start of planning, development, and/or delivery of the activity.  In addition, a peer-review of content concluded that all presentation/activity content is evidence-based, balanced, and free from commercial/promotional bias (Note:  peer review was conducted by instructors/planners, who reviewed content other than their own).
 
Nursing Conflicts of Interest: A conflict of interest occurs when an individual has an opportunity to affect or impact educational content with which he or she may have a commercial interest or a potentially biasing relationship of a financial nature. All planners and presenters/authors/content reviewers must disclose the presence or absence of a conflict of interest relative to this activity. The activity’s Nurse Planner has determined that no one who has the ability to control the content of this CNE activity – planning committee members and presenters/authors/content reviewers – has a conflict of interest.
 
 
 
 
Continuing Education Credit
 
Pharmacy Accreditation
 
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is accredited for pharmacists, up to a total of 6.0 contact hours as follows:
 
  1.25 CE hours
Module 1: Pharmacotherapeutic Management of Heart Failure *
  1.25 CE hours 
Module 2: Pharmacotherapeutic Management of High Cholesterol *
  2 CE hours 
Module 3: Heart Failure and High Cholesterol - Applying Guidelines and Evidence-Based Data
  1.5 CE hours 
Module 4: Heart Failure and High Cholesterol - Comorbidities and Emerging Therapies
**  The number of credit hours available to pharmacists differs from the number of credit hours available to nurses.  
 
Release Date:     12/20/2021
Expiration Date:  12/20/2023

 
Nursing Accreditation
 
University of Texas at Austin School of Nursing is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This CNE activity has been jointly provided by University of Texas at Austin School of Nursing collaboratively with The University of Texas as Austin College of Pharmacy.
 
Requirements for Nursing Successful Completion: To receive contact hours for this continuing education activity, the participant must sign in or register, complete the entire module, and complete and submit the evaluation form. Once successful completion has been verified, a “Certificate of Successful Completion” will be awarded for nurses, up to a total of 6.5 contact hours as follows:
 
  1.5 CE hours 
Module 1: Pharmacotherapeutic Management of Heart Failure *
  1.5 CE hours 
Module 2: Pharmacotherapeutic Management of High Cholesterol *
  2 CE hours 
Module 3: Heart Failure and High Cholesterol - Applying Guidelines and Evidence-Based Data
  1.5 CE hours 
Module 4: Heart Failure and High Cholesterol - Comorbidities and Emerging Therapies
    * The number of credit hours available to nurses differs from the number of credit hours available to pharmacists.
 
Release Date:     12/20/2021
Expiration Date:  12/20/2023
 
Learning Outcome: At the conclusion of this learning activity, the RN will verbalize the desire to change practice due to knowledge gain regarding application of the latest evidence-based guidelines and data on available treatments for heart failure and high cholesterol in order to develop patient-centered treatment plans.
 
Proof of Credit
 
Pharmacists:  It is the participant's responsibility to confirm that CPE credits have successfully uploaded to their CPE Monitor profile following the completion of each module evaluation (within 60 days of completing the evaluation).  To address credit discrepancies, contact UT CPE within 60 days of completing the module in question.
 
All Other Learners:  Select "View/Print CE Credit" at the top of the screen to view your updated certificate with your completed credit hours.
 
Questions / CE Contact Information 
 
 
 
 
 
Registration Fee
 
There is no cost to participate in this CE activity.
 
 
 
 
Program Funding
 
This program was sponsored in-part by an educational grant from Novartis.
 

Fee

$0.00

CE Hours

6.00

CE Units

0.600

Activity Type

  • Application

Support/Credits

 
 
Activity Access
 
TO START:  Register / Create Your CPE Profile
 
  • Register for this activity using the GREEN button at the bottom of the page (if you have not claimed CPE credit through this UT Austin College of Pharmacy CPE site before, you will also be prompted to create a CPE profile before you can register for the activity).  Pharmacists:  Be sure to enter your NABP e-ID and DOB correctly! 
  • Save your email & password for easier access when you return to complete future modules.
  • Once you are registered & logged in (your name appears in the gray menu bar / upper right screen), select the module from the list below that you wish to take and follow the instructions for that module.
Future Modules:  Logging Back In  
 
  • From this page, click Pending/Private Programs in the gray menu bar at the top of the page.
  • Enter your email/password at the prompt.
  • On the next screen that follows, select the activity title from the list of Online CE courses.
  • Continue the activity by selecting and completing the modules below.
Questions?  
 


 

 

   

Instructions
 
** REMINDER:  You must be registered and logged into the activity to view course content (see Activity Access up above).
 
  1. View the Presentation Video (located beneath Videos) and the presentation slides (located beneath Course Materials).
  2. Complete the Case Exercise (llocated beneath Course Materials) as you view the faculty-guided Case Discussion Video (located beneath Videos).  NOTE:  You may complete the Case Exercise by typing answers directly on the document or you may print it and write out your answers.  You will need your completed Case Exercise to answer questions on the activity Evaluation at the end of the module.
  3. Take the Test after viewing both videos and completing the case exercise (score > 70% within 5 attempts).
  4. Complete the Evaluation (with the help of your completed Case Exercise), to claim CE credit for this individual module.
 
Activity Details
 

Objectives

  • Review the prevalence and impact on health outcomes of heart failure and the potentially greater impact when accompanied by comorbid conditions.
  • Explain the pathophysiology and typical symptomology of the different stages of heart failure.
  • Examine medications utilized in the management of heart failure, with emphasis on newer and novel agents that have been introduced in recent years, by outlining such factors as mechanisms of action, dosing, contraindications, and adverse effects.

Speaker(s)/Author(s)

James A. Karboski picture

James A. Karboski, Pharm.D.
Clinical Associate Professor, The University of Texas at Austin College of Pharm


Brief Bio : James A. Karboski, Pharm.D. is a Clinical Associate Professor of Pharmacy and Assistant Division Head in the Health Outcomes and Pharmacy Practice Division at the University of Texas at Austin College of Pharmacy. He holds the Neill B. Walsdorf Fellowship in Pharmacy. Dr. Karboski earned a Bachelor of Pharmacy degree from Washington State University in 1985. Subsequently, Dr. Karboski earned his Doctor of Pharmacy degree from the University of Texas at Austin and the University of Texas Health Sciences Center at San Antonio in 1987. He continued his training in Texas where he completed a Clinical Sciences Fellowship in Pharmacokinetics at the University of Texas at Austin.

Activity Number

0067-0000-21-210-H01-P/T

Release Date: Dec 20, 2021
Credit Expiration Date: Dec 20, 2023

CE Hours

1.25
   

   

Instructions
 
** REMINDER:  You must be registered and logged into the activity to view course content (see Activity Access up above).
 
  1. View the Presentation Video (located beneath Videos) and the presentation slides (located beneath Course Materials).
  2. Complete the Case Exercise (llocated beneath Course Materials) as you view the faculty-guided Case Discussion Video (located beneath Videos).  NOTE:  You may complete the Case Exercise by typing answers directly on the document or you may print it and write out your answers.  You will need your completed Case Exercise to answer questions on the activity Evaluation at the end of the module.
  3. Take the Test after viewing both videos and completing the case exercise (score > 70% within 5 attempts).
  4. Complete the Evaluation (with the help of your completed Case Exercise), to claim CE credit for this individual module.
 
Activity Details
 

Objectives

  • Review the prevalence and impact on health outcomes of high cholesterol and the potentially greater impact when accompanied by comorbid conditions.
  • Explain the pathophysiology and typical symptomology of high cholesterol.
  • Examine medications utilized in the management of high cholesterol, with emphasis on newer and novel agents that have been introduced in recent years, by outlining such factors as mechanisms of action, dosing, contraindications, and adverse effects.

Speaker(s)/Author(s)

Rebekka Adamson picture

Rebekka Adamson, PharmD, BCCP
Clinical Pharmacy Specialist, Cardiology/Internal Medicine, Dell Seton Medical Center


Brief Bio : Rebekka Adamson is the cardiology clinical pharmacist at Dell Seton Medical Center in Austin, Texas. She completed her undergraduate training at Clemson University in South Carolina, her Doctorate of Pharmacy at the Medical University of South Carolina in Charleston, South Carolina, and then went on to complete her PGY-1 residency in Austin, Texas at Seton Healthcare Family. To pursue her passion for cardiology, Rebekka went on to complete a PGY-2 residency in cardiology pharmacy at Advent Health Orlando in Orlando, Florida. Rebekka’s clinical interests include anticoagulation, heart failure, and electrophysiology.

Activity Number

0067-0000-21-211-H01-P/T

Release Date: Dec 20, 2021
Credit Expiration Date: Dec 20, 2023

CE Hours

1.25
   

   

Instructions
 
** REMINDER:  You must be registered and logged into the activity to view course content (see Activity Access up above).
 
  1. View the Presentation Video (located beneath Videos) and the presentation slides (located beneath Course Materials).
  2. Complete the Case Exercise (llocated beneath Course Materials) as you view the faculty-guided Case Discussion Video (located beneath Videos).  NOTE:  You may complete the Case Exercise by typing answers directly on the document or you may print it and write out your answers.  You will need your completed Case Exercise to answer questions on the activity Evaluation at the end of the module.
  3. Take the Test after viewing both videos and completing the case exercise (score > 70% within 5 attempts).
  4. Complete the Evaluation (with the help of your completed Case Exercise), to claim CE credit for this individual module.
 
Activity Details
 

Objectives

  • Discuss current guidelines and evidence-based data for the treatment of heart failure.
  • Discuss current guidelines and evidence-based data for the treatment of high cholesterol.
  • Examine how current guidelines and evidence-based data impact the treatment of heart failure and/or high cholesterol using patient scenarios/case studies.

Speaker(s)/Author(s)

Kristin M. Janzen, PharmD, BCPS picture

Kristin M. Janzen, PharmD, BCPS
Clinical Assistant Professor, University of Texas at Austin College of Pharmacy

Activity Number

0067-0000-21-212-H01-P/T

Release Date: Dec 20, 2021
Credit Expiration Date: Dec 20, 2023

CE Hours

2.00
   

   

Instructions
 
** REMINDER:  You must be registered and logged into the activity to view course content (see Activity Access up above).
 
  1. View the Presentation Video (located beneath Videos) and the presentation slides (located beneath Course Materials).
  2. Complete the Case Exercise (llocated beneath Course Materials) as you view the faculty-guided Case Discussion Video (located beneath Videos).  NOTE:  You may complete the Case Exercise by typing answers directly on the document or you may print it and write out your answers.  You will need your completed Case Exercise to answer questions on the activity Evaluation at the end of the module.
  3. Take the Test after viewing both videos and completing the case exercise (score > 70% within 5 attempts).
  4. Complete the Evaluation (with the help of your completed Case Exercise), to claim CE credit for this individual module.
 
Activity Details
 

Objectives

  • Examine the prevalence and impact of comorbidities in patients with heart failure and/or high cholesterol.
  • Discuss emerging/future treatments for heart failure and high cholesterol and the potential implications for practice.
  • Explain key considerations to writing up a case report and treatment plan for a new patient presenting with heart failure and/or high cholesterol plus comorbidities.
  • Develop a case report and treatment plan for the management of heart failure and/or high cholesterol using a real-world patient/case, taking into consideration current treatment guidelines, evidence-based data, and patient-specific factors like comorbidities.

Speaker(s)/Author(s)

Kristin M. Janzen, PharmD, BCPS picture

Kristin M. Janzen, PharmD, BCPS
Clinical Assistant Professor, University of Texas at Austin College of Pharmacy

Activity Number

0067-0000-21-213-H01-P/T

Release Date: Dec 20, 2021
Credit Expiration Date: Dec 20, 2023

CE Hours

1.50